WHO introduces its first green pharmaceuticals framework, advancing sustainable drug regulation worldwide.
As climate change increases health risks worldwide, healthcare systems need to focus more on sustainability. The healthcare sector contributes about 5% of global carbon emissions, making greener practices essential for a healthier planet (1✔ ✔Trusted Source
Greener Pharmaceuticals’ Regulatory Highway
).
Through its Department of Regulation and Prequalification, WHO is urging regulators, pharma companies, and healthcare organizations to adopt sustainable solutions that reduce the environmental impact of medicines and healthcare services.
Advertisement
WHO’s New Framework Promotes Greener Pharma
The World Health Organization (WHO) has launched its first global framework to help regulators promote greener pharmaceuticals.
The initiative focuses on sustainable pharma regulations to ensure medicines remain safe, effective, and available to patients worldwide.
The framework also encourages regulators and pharma companies to reduce the environmental impact of medicines at every stage, from research and development to manufacturing, supply, and disposal.
Advertisement
Why Did WHO Introduce the Green Pharma Initiative?
WHO introduced this initiative to address the growing environmental impact left by the pharmaceutical and healthcare sectors.
Medicine production can contribute to carbon emissions, chemical waste, and resource depletion, which can harm ecosystems and worsen climate-related health risks.
The framework aims to encourage greener pharma practices while ensuring medicines remain safe, effective, and accessible worldwide.
Advertisement
Reducing the Environmental Impact of Medicines
As the pharmaceutical and healthcare sectors contribute to environmental challenges, WHO’s framework encourages sustainable drug manufacturing, better resource management, and greener practices to reduce the environmental footprint of medicines.
By adopting sustainable approaches, the pharma industry can help tackle climate change while continuing to provide essential medicines worldwide.
Dr. Rogério Gaspar, Director of WHO’s Department of Regulation and Prequalification, said, “This framework demonstrates how medicine regulators can create the conditions for innovation to flourish while continuing to uphold the highest standards of quality, safety, and efficacy. By making full use of existing regulatory tools, they can help advance more sustainable pharma systems that benefit both people and the planet.”
Key Steps to Make Pharmaceuticals Greener
The WHO framework calls for stronger global coordination to measure, report, and compare pharmaceutical emissions. Using common standards and reporting methods can improve transparency, reduce repeated efforts, and help regulators and manufacturers monitor environmental progress.
The framework also focuses on innovation and smarter regulatory approaches. Expanding digital regulatory services, providing early scientific guidance, simplifying sustainability-related changes after approval, and improving collaboration between regulators can help eco-friendly innovations reach patients faster while maintaining medicine safety.
From Framework to Action
The green pharma framework was developed using scientific evidence, stakeholder feedback, and discussions from WHO’s Global Regulators Summit 2026 (2✔ ✔Trusted Source
WHO launches first global framework to help regulators advance greener pharmaceuticals
).
It highlights that reducing pharmaceutical emissions requires collaboration among regulators, pharmaceutical companies, governments, researchers, and healthcare organizations.
WHO will work with global regulatory networks and partners to support knowledge sharing, pilot initiatives, and sustainable pharmaceutical practices while strengthening alignment across countries.
Prevention is better than cure, and protecting the planet today can help prevent future health risks.
Nevertheless, WHO’s greener pharma framework marks a major step toward sustainable healthcare. By encouraging innovation, collaboration, and responsible practices, it aims to create medicines that protect both people and the planet.
References:
- Greener Pharmaceuticals’ Regulatory Highway – (https://www.who.int/publications/m/item/greener-pharmaceuticals-regulatory-highway)
- WHO launches first global framework to help regulators advance greener pharmaceuticals – (https://www.who.int/news/item/29-07-2026-who-launches-first-global-framework-to-help-regulators-advance-greener-pharmaceuticals)
Source-Medindia